Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study.

[1]  Wenhong Zhang,et al.  2019 Chinese Clinical Practice Guidelines for the Prevention of Mother-to-child Transmission of Hepatitis B Virus , 2020, Journal of clinical and translational hepatology.

[2]  Steven R. Martin,et al.  Real‐world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate‐treated chronic hepatitis B pregnant patients in North America , 2020, Alimentary pharmacology & therapeutics.

[3]  R. Chou,et al.  Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. , 2020, The Lancet. Infectious diseases.

[4]  Shiliang Liu,et al.  Efficacy and safety of continuous antiviral therapy from preconception to prevent perinatal transmission of hepatitis B virus , 2020, Scientific Reports.

[5]  Xuesong Gao,et al.  Efficacy and Safety of Lamivudine or Telbivudine in Preventing Mother-to-Child Transmission of Hepatitis B Virus: A Real-World Study , 2020, BioMed research international.

[6]  M. Giles,et al.  Chronic hepatitis B infection and the risk of gestational diabetes: a cross‐sectional study , 2020, BJOG : an international journal of obstetrics and gynaecology.

[7]  Xuesong Gao,et al.  The safety and efficacy of tenofovir disoproxil fumarate used throughout pregnancy for mothers with chronic hepatitis B , 2019, European Journal of Gastroenterology and Hepathology.

[8]  F. Cao,et al.  Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real‐life practice , 2019, Journal of viral hepatitis.

[9]  S. Belle,et al.  Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study , 2019, The American journal of gastroenterology.

[10]  J. Lewis,et al.  Incidence, determinants and outcomes of pregnancy‐associated hepatitis B flares: A regional hospital‐based cohort study , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[11]  B. McMahon,et al.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance , 2018, Hepatology.

[12]  M. Nguyen,et al.  Serum Aminotransferase Flares in Pregnant and Postpartum Women With Current or Prior Treatment for Chronic Hepatitis B , 2017, Journal of clinical gastroenterology.

[13]  D. Zhang,et al.  Prospective cohort study on the efficacy and safety of telbivudine used throughout pregnancy in blocking mother‐to‐child transmission of hepatitis B virus , 2017, Journal of viral hepatitis.

[14]  H. Tang,et al.  Safety and efficacy of telbivudine for chronic hepatitis B during the entire pregnancy: Long‐term follow‐up , 2017, Journal of viral hepatitis.

[15]  Thomas Berg,et al.  EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.

[16]  Anhua Hao,et al.  Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission , 2017, BMC Gastroenterology.

[17]  F. Cao,et al.  Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus , 2016, Journal of gastroenterology and hepatology.

[18]  M. Nguyen,et al.  Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B , 2016, The American Journal of Gastroenterology.

[19]  Shuqin Zhang,et al.  Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. , 2016, The New England journal of medicine.

[20]  B. McMahon,et al.  Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis , 2016, Hepatology.

[21]  Mei-Hwei Chang,et al.  Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother‐to‐infant transmission of hepatitis B virus , 2015, Hepatology.

[22]  S. Lewin,et al.  Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B , 2014, Gut.

[23]  S. Locarnini,et al.  Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. , 2014, Journal of hepatology.

[24]  H. Cai,et al.  Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy , 2013, Journal of viral hepatitis.

[25]  J. Jang,et al.  Outcome after discontinuing antiviral agents during pregnancy in women infected with hepatitis B virus. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[26]  H. Cai,et al.  Safety of lamivudine treatment for chronic hepatitis B in early pregnancy. , 2012, World journal of gastroenterology.

[27]  Wei Zhao,et al.  A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. , 2011, Journal of hepatology.

[28]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[29]  N. Andrews,et al.  Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.